NCT06179914

Brief Summary

Validation of Resilience Models about Cancer in Adolescence and Youth in Taiwan

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
223

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 2, 2020

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 26, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 26, 2022

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

November 23, 2023

Completed
29 days until next milestone

First Posted

Study publicly available on registry

December 22, 2023

Completed
Last Updated

December 22, 2023

Status Verified

November 1, 2023

Enrollment Period

1.9 years

First QC Date

November 23, 2023

Last Update Submit

December 12, 2023

Conditions

Keywords

ResilienceHopesocial supportCopingadolescent and young adultuncertainty

Outcome Measures

Primary Outcomes (2)

  • Herth Hope Index (HHI)

    Herth Hope Index (HHI) has 12 items. The12 items developed by Herth (1992) measures adults hope and contains three factors: cognitive-temporal (positive and desired outcome in the future), affective-behavioral (a feeling of confident with the reality-based goals and desirable outcomes), and affiliative-contextual (interconnect between self and others)(Herth, 1992). A higher score indicates a higher degree of hope.

    1 year

  • Resilience in Illness Scale (HARS)

    HARS is a single factor scale, consisting of 13 items that measure how participants feel or think about managing their health since diagnosis. The internal consistency reliability (0.84 to 0.86) and content validity have been tested by previous qualitative research (Haase \& Marcia, 1994; Haase \& Philips, 2004). Participants are asked to mark how much they agree or disagree with each sentence using response options from 1 (strongly disagree) to 6 (strongly agree) (Haase, et al., 1999). Higher total scores indicate a higher degree of resilience.

    1 year

Secondary Outcomes (9)

  • Symptom Distress Scale (SDS)

    1 year

  • mishel Uncertainty in Illness Scale - Revised

    1 year

  • Jalowiec Coping Scale-Revised

    1 year

  • Spiritual Perspective Scale (SPS)

    1 year

  • Perceived Social Support (PSS)

    1 year

  • +4 more secondary outcomes

Study Arms (1)

Adolescence and Youth with cancer

Participants were diagnosed with cancer before 18 years old and aged between 10 and 24 years

Eligibility Criteria

Age10 Years - 24 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

childhood cancer at age between 10 and 24

You may qualify if:

  • Diagnosed with cancer before 18 years old
  • Aged between 10 and 24 years
  • Received cancer treatment or completed treatment

You may not qualify if:

  • Diagnosis of mental problems (developmental delay or psychiatric illness)
  • At the end of life

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kaohsiung Medical University

Kaohsiung City, 80361, Taiwan

Location

Related Publications (11)

  • Yu J, Dong H, Song Y, Zhu F. Influencing Factors of Hope Among Chinese Patients With Hematological Malignancies From the Perspective of Positive Psychology: A Cross-sectional Study. Cancer Nurs. 2022 Nov-Dec 01;45(6):465-472. doi: 10.1097/NCC.0000000000001035. Epub 2022 Jan 13.

  • Yu J, Song H. Prevalence and risk factors of loneliness among patients with hematological malignancies. Medicine (Baltimore). 2022 Dec 2;101(48):e31900. doi: 10.1097/MD.0000000000031900.

  • Borrescio-Higa F, Valdes N. The Psychosocial Burden of Families with Childhood Blood Cancer. Int J Environ Res Public Health. 2022 Jan 5;19(1):599. doi: 10.3390/ijerph19010599.

  • Linder LA, Hooke MC. Symptoms in Children Receiving Treatment for Cancer-Part II: Pain, Sadness, and Symptom Clusters. J Pediatr Oncol Nurs. 2019 Jul/Aug;36(4):262-279. doi: 10.1177/1043454219849578.

  • Sharp K, Tillery R, Long A, Wang F, Pan H, Phipps S. Trajectories of resilience and posttraumatic stress in childhood cancer: Consistency of child and parent outcomes. Health Psychol. 2022 Apr;41(4):256-267. doi: 10.1037/hea0001132. Epub 2021 Dec 2.

  • Rosales P, Evangelista L, Guo Y, Agbayani CG, Kain ZN, Fortier MA. Exploring Differences in Perceived Satisfaction, Resilience, and Achievement Between Hispanic and Non-Hispanic White Childhood Cancer Survivors. J Pediatr Health Care. 2021 Mar-Apr;35(2):196-204. doi: 10.1016/j.pedhc.2020.10.003. Epub 2021 Jan 28.

  • Li Y, Ni N, Zhou Z, Dong J, Fu Y, Li J, Luan Z, Peng X. Hope and symptom burden of women with breast cancer undergoing chemotherapy: A cross-sectional study. J Clin Nurs. 2021 Aug;30(15-16):2293-2300. doi: 10.1111/jocn.15759. Epub 2021 Mar 23.

  • Taylor EJ, Petersen C, Oyedele O, Haase J. Spirituality and Spiritual Care of Adolescents and Young Adults with Cancer. Semin Oncol Nurs. 2015 Aug;31(3):227-41. doi: 10.1016/j.soncn.2015.06.002. Epub 2015 Jun 6.

  • Haase JE. The adolescent resilience model as a guide to interventions. J Pediatr Oncol Nurs. 2004 Sep-Oct;21(5):289-99; discussion 300-4. doi: 10.1177/1043454204267922.

  • Decker C, Phillips CR, Haase JE. Information needs of adolescents with cancer. J Pediatr Oncol Nurs. 2004 Nov-Dec;21(6):327-34. doi: 10.1177/1043454204269606.

  • Laksmita OD, Chung MH, Liao YM, Haase JE, Chang PC. Predictors of resilience among adolescent disaster survivors: A path analysis. J Adv Nurs. 2020 Aug;76(8):2060-2071. doi: 10.1111/jan.14396. Epub 2020 May 19.

MeSH Terms

Conditions

Neoplasms

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 23, 2023

First Posted

December 22, 2023

Study Start

November 2, 2020

Primary Completion

September 26, 2022

Study Completion

September 26, 2022

Last Updated

December 22, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations